AVBP

NASDAQ · Biotechnology

Arrivent Biopharma Inc

Small-Cap Stocks Biotech Stocks Healthcare Stocks

$29.99

-1.10 (-3.54%)

As of May 9, 1:40 AM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 18 95%

Hold 1 5%

Sell 0 0%

Price Target

Analyst Price Target -14.6% upside

Low Target $15.99

Average Target $25.60

High Target $32.44

Current Price $29.99

Current
$29.99

Target
$25.60

$15.99 $25.60 avg $32.44

Scenario Analysis

Bear Case

$15.99

-46.7%

Low target

Base Case

$25.60

-14.6%

Avg target

Bull Case

$32.44

+8.2%

High target

Risk/Reward

0.2x

Unfavorable

Price in Context

52-Week High

$32.14

-6.7% from high

52-Week Low

$16.10

+86.3% from low

Target vs 52W High

$25.60

-20.3% vs high

Next Earnings Report

May 13, 2026

until earnings

EPS Est: $-0.91

Earnings in 2 days. Analyst targets may shift significantly after the report.

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	75%	$257.58	+27.8%
AMGN Amgen Inc	Hold	44	48%	$190.87	-42.5%
GILD Gilead Sciences Inc	Strong Buy	39	79%	$362.68	+176.2%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	+2.0%
REGN Regeneron Pharmaceuticals	Strong Buy	38	79%	$76.80	-89.3%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-65.3%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-19.5%
INSM Insmed Inc	Strong Buy	28	96%	$143.40	+41.5%